Ifp Advisors, Inc Amicus Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 22,520 shares of FOLD stock, worth $220,470. This represents 0.01% of its overall portfolio holdings.

Number of Shares

22,520

Previous 22,312 0.93%

Holding current value

$220,470

Previous $262,000 14.89%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$9.04 - $11.75 $1,880 - $2,444	208 Added 0.93%	22,520 $223,000
Q1 2024 Jul 30, 2024	BUY	$11.43 - $14.24 $7,818 - $9,740	684 Added 3.16%	22,312 $262,000
Q4 2023 Jan 09, 2024	BUY	$9.97 - $14.52 $15,204 - $22,143	1,525 Added 7.59%	21,628 $306,000
Q3 2023 Oct 12, 2023	SELL	$11.78 - $13.86 $179,974 - $211,753	-15,278 Reduced 43.18%	20,103 $244,000
Q2 2023 Aug 04, 2023	SELL	$10.72 - $13.3 $4,384 - $5,439	-409 Reduced 1.14%	35,381 $444,000
Q1 2023 Apr 18, 2023	SELL	$10.91 - $13.54 $12,917 - $16,031	-1,184 Reduced 3.2%	35,790 $396,000
Q4 2022 Feb 07, 2023	BUY	$9.89 - $12.7 $53,218 - $68,338	5,381 Added 17.03%	36,974 $610,000
Q3 2022 Nov 08, 2022	BUY	$9.82 - $12.75 $7,914 - $10,276	806 Added 2.62%	31,593 $519,000
Q2 2022 Sep 06, 2022	BUY	$6.23 - $11.12 $191,803 - $342,351	30,787 New	30,787 $505,000
Q2 2022 Aug 12, 2022	SELL	$6.23 - $11.12 $191,803 - $342,351	-30,787 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$7.89 - $12.48 $141,728 - $224,178	17,963 Added 140.07%	30,787 $291,000
Q1 2022 Aug 08, 2022	BUY	$7.89 - $12.48 $1,049 - $1,659	133 Added 1.05%	12,824 $121,000
Q4 2021 Jan 12, 2022	BUY	$9.82 - $12.44 $20,533 - $26,012	2,091 Added 19.73%	12,691 $143,000
Q3 2021 Oct 06, 2021	SELL	$8.74 - $11.84 $13,791 - $18,683	-1,578 Reduced 12.96%	10,600 $102,000
Q2 2021 Jul 13, 2021	BUY	$8.71 - $10.72 $1,724 - $2,122	198 Added 1.65%	12,178 $118,000
Q1 2021 Apr 30, 2021	BUY	$9.2 - $23.86 $103,665 - $268,854	11,268 Added 1582.58%	11,980 $119,000
Q4 2020 Jan 25, 2021	BUY	$13.47 - $24.89 $7,516 - $13,888	558 Added 362.34%	712 $15,000
Q3 2020 Oct 29, 2020	BUY	$12.89 - $15.89 $1,985 - $2,447	154 New	154 $2,000
Q2 2020 Aug 05, 2020	BUY	$8.86 - $15.69 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$6.63 - $11.16 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$7.48 - $10.75 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$8.02 - $13.25 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	SELL	$10.04 - $13.92 $210 - $292	-21 Closed	0 $0
Q3 2018 Oct 25, 2018	SELL	$11.6 - $16.54 $800 - $1,141	-69 Reduced 76.67%	21 $0
Q2 2018 Aug 07, 2018	BUY	$13.13 - $17.09 $905 - $1,179	69 Added 328.57%	90 $0
Q4 2017 Jan 24, 2018	SELL	$12.51 - $16.24 $15,012 - $19,487	-1,200 Reduced 98.28%	21 $0
Q3 2017 Oct 30, 2017	SELL	$11.74 - $15.78 $11,493 - $15,448	-979 Reduced 44.5%	1,221 $18,000
Q2 2017 Jun 03, 2019	BUY	N/A	2,000 Added 1000.0%	2,200 $22,000
Q2 2016 Jun 03, 2019	BUY	N/A	200	200 $1,000

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.75B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account